Radioprotective pharmacological agent comprises 1-isobutanoyl-2-isopropylisothiourea phosphate as active substance with structural formula, and provides active substance in composition of solutions for injection or infusion
2020-04-15
专利权人NAT MEDICAL RADIOLOGY RES CENT (NAME-Non-standard)
申请日期2020-04-15
专利号RU2020113581-A; RU2733883-C2
成果简介NOVELTY - The radioprotective pharmacological agent comprises 1-isobutanoyl-2-isopropylisothiourea phosphate as an active substance with the structural formula. The active substance is provided in the composition of solutions for injection or infusion. The anti-radiation effect is provided in the wide range of doses of the active substance. The active ingredient is provided in solid dosage forms for oral administration. USE - Radioprotective pharmacological agent. ADVANTAGE - The complications of radiation therapy are prevented. The high anti-radiation efficiency is prevented when using small, relatively safe doses of the active substance.
IPC 分类号A61K-009/50 ; A61K-031/155 ; A61P-043/00 ; C07C-335/32
国家俄罗斯
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/23166
专题中国科学院新疆生态与地理研究所
作者单位
NAT MEDICAL RADIOLOGY RES CENT (NAME-Non-standard)
推荐引用方式
GB/T 7714
FILIMONOVA M V,SHEVCHENKO L I,FALIMONOV A S,et al. Radioprotective pharmacological agent comprises 1-isobutanoyl-2-isopropylisothiourea phosphate as active substance with structural formula, and provides active substance in composition of solutions for injection or infusion. RU2020113581-A; RU2733883-C2[P]. 2020.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。